Celebrating Hong Kong’s century-old Dragon Boat heritage with a large-scale installation to design your own boat
HONG KONG SAR – Media OutReach Newswire – 18 June 2026 – Sun Life has proudly supported local dragon boat activities to help preserve this cultural tradition. To mark the 50thanniversary of the iconic “Hong Kong International Dragon Boat Races”, the company has partnered with the Hong Kong Tourism Board to scale up its support as the title sponsor of both the “Sun Life Hong Kong International Dragon Boat Festival” and the “Sun Life Hong Kong International Dragon Boat Races”, bringing the annual event to a global stage to allow locals and visitors to experience the festive energy.
Sun Life Partners with the Hong Kong Tourism Board to Take Dragon Boat Celebrations to New Heights as Title Sponsor of the “Sun Life Hong Kong International Dragon Boat Festival” and “Sun Life Hong Kong International Dragon Boat Races”
This year’s celebration unfolds as a 13-day dragon boat carnival along the Tsim Sha Tsui Promenade, running from 19 June to 1 July. Blending traditions and modern elements, the festival features exciting races, festive delicacies and immersive cultural experiences, creating an unforgettable summer destination for locals as well as tourists from Chinese Mainland and overseas. Sun Life has also curated a series of exclusive activities to infuse the community with even more joy and energy.
Adley Low, Chief Client and Marketing Officer of Sun Life Hong Kong Limited, said: “Dragon boat racing is a powerful symbol of Hong Kong’s cultural identity and a meaningful way to bring people together. We are thrilled to partner with the Hong Kong Tourism Board as the title sponsor of the ‘Sun Life Hong Kong International Dragon Boat Festival’ and ‘Sun Life Hong Kong International Dragon Boat Races’, to present this international event on an even bigger scale this year. As Sun Life prepares to welcome our 135th anniversary in Hong Kong, we are proud to contribute to the local mega-event economy while deepening our connections with the community, reflecting our ongoing commitment to helping Clients live healthier, more fulfilling lives.”
Design your own dragon boat at the “Sun Life HK Dragon Boat Co-Creation Zone”
The “Sun Life HK Dragon Boat Co-Creation Zone” is an interactive installation located on the ground floor of the K11 MUSEA Promenade in Tsim Sha Tsui, open from 19 June to 1 July. Visitors can unleash their creativity by designing their own dragon boat, experience the thrill of paddling and capture these moments through AI-generated personalized short videos. There will be also a dedicated photo spot that offers a scenic setting for memorable photo opportunities. For online engagement, the public can join in the excitement via Sun Life’s official social media platforms (Facebook and Instagram), where interactive games will bring the buzz of the Dragon Boat Festival anytime, anywhere.
Event details:
Sun Life HK Dragon Boat Co-Creation Zone
Date
19 June (Friday) to 1 July (Wednesday)
Time#
Monday to Thursday: 3:00pm to 9:00pm
Friday to Sunday and public holidays: 10:00am to 9:00pm
Venue
K11 Musea Promenade, Tsim Sha Tsui (Next to the Avenue of Stars)
Fee
Free of charge
Remarks: Terms and conditions apply. For details, please visit Sun Life’s official Facebookor Instagrampage or refer to the on-site information. # Opening hours are for reference only and are subject to change without prior notice.
Hashtag: #SunLifeHongKong
The issuer is solely responsible for the content of this announcement.
About Sun Life
Sun Life is a leading international financial services organisation providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including Canada, the U.S., the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of 31 March 2026, Sun Life had total assets under management of $1.58 trillion. For more information, please visit www.sunlife.com.
Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF. Sun Life Financial Inc. is the holding company of Sun Life Assurance Company of Canada. Sun Life Hong Kong Limited (incorporated in Bermuda with limited liability) is a wholly-owned subsidiary of Sun Life Assurance Company of Canada and operates in Hong Kong.
City’s first hospital to adopt Renewable Diesel Blend R33, reducing up to 30% lifecycle CO2e emissions
HONG KONG SAR – Media OutReach Newswire – 18 June 2026 – Shell Hong Kong Limited (Shell) and St. Paul’s Hospital on Tuesday held the “Shell x St. Paul’s Hospital – Integrated Decarbonisation Solutions Kick-off Ceremony”, reinforcing their shared commitment to sustainable development. As one of the world’s largest suppliers of biofuels, Shell has been promoting renewable diesel as a practical, lower-carbon energy solution. St. Paul’s Hospital is the first hospital in Hong Kong to adopt Shell Renewable Diesel Blend R33¹ for its boiler system. The switch required no modification to its existing equipment and offers up to 30%2 less CO2e emissions on a life cycle basis3 compared to EN 590 B0 diesel4. In addition, St. Paul’s Hospital installed Shell Recharge electric vehicle charging facilities in its parking lot and joined Shell’s CO2 Compensation Programme as part of its low-carbon initiatives.
(From left) Mr. Dick Chan, General Manager of Shell Commercial Fuels – Hong Kong and Macau; Ms. Berry Wong, General Manager of Shell Mobility – Hong Kong and Macau; Mr. Hu Chuan, Vice President of Shell Mobility & Convenience – China; Sr. Nancy Cheung, Managing Director of St. Paul’s Hospital; Mr. Gilbert Lee, General Manager of St. Paul’s Hospital; and Mr. Keith Ho, Facilities Manager of St. Paul’s Hospital, witness the launch of the “Integrated Decarbonisation Solutions”.
First hospital in Hong Kong: adopting renewable diesel for boiler systems
Shell is committed to “Power Progress Together” by working together with their customers and partners, to provide the energy products that people need to power their lives and businesses today, while helping to build the low-carbon energy system of the future. With Shell’s support, St. Paul’s Hospital has pioneered a healthcare first in Hong Kong to implement Shell Renewable Diesel Blend R331 to power its boiler system.
Mr. Dick Chan, General Manager of Shell Commercial Fuels – Hong Kong and Macau, and Sr. Nancy Cheung, Managing Director of St. Paul’s Hospital, sign an agreement on “Integrated Decarbonisation Solutions – CO2 Compensation Programme “, marking their continued commitment to decarbonisation.
Renewable diesel: enabling value chain decarbonisation for businesses
In response to St. Paul’s Hospital’s need for a stable low-carbon energy solution, Shell introduced Renewable Diesel Blend R331, which offers up to 30%2 less CO2e emissions on a life cycle basis3 compared to EN 590 B0 diesel4, helping the hospital reduce value chain emissions and meet its Scope 1 and Scope 2 targets.
Compatible with conventional diesel equipment
The launch of Shell Renewable Diesel marks a significant milestone in Shell’s support in the energy transition journey in Hong Kong. Mr. Dick Chan, General Manager of Shell Commercial Fuels – Hong Kong and Macau of Shell Hong Kong Limited, said: “We are honoured to witness St. Paul’s Hospital becoming a low-carbon promoter in Hong Kong’s healthcare sector, as the first to adopt Shell Renewable Diesel Blend R331. This represents the shared commitment of both the energy sector and the healthcare sector to work together for a sustainable future.”
Businesses selecting sustainable low-carbon energy solutions often face challenges such as capital investment, equipment compatibility, and operational impact. Shell Renewable Diesel is fully compatible with conventional diesel boilers or engines and can serve as a direct replacement fuel without any modifications or adding new equipment5, helping businesses lower costs and emissions. It also reduces regulated air pollutants6, making it suitable for use across various industries including construction, transport and logistics, industrial operations, and healthcare.
Comprehensive technical support for a smooth transition
A hospital’s boiler system is essential to daily operations. It supplies hot water and steam for the central heating system, wards, operating theatres, laundry services, and sterilisation equipment. Any disruption to boiler operations would have a significant impact on the hospital functioning. For this reason, St. Paul’s Hospital places great importance on the stability of its fuel supply. Switching to Shell Renewable Diesel Blend R331 required no modification to the hospital’s existing boiler system. To ensure a smooth transition, Shell provided professional technical support and conducted comprehensive inspections of the boiler system before the switch to ensure continued safe and reliable operation.
Mr. Gilbert Lee, General Manager of St. Paul’s Hospital, welcomed the collaboration. He said: “It is an undeniable fact that renewable energy has become a key direction of future energy transition, aligning with the global trend towards low carbon and environmental sustainability. Looking ahead, St. Paul’s Hospital will continue to collaborate with different sectors to promote more practical and effective low-carbon measures, contributing to a greener and healthier future for both the hospital and the wider community.”
Advancing low-carbon operations towards a sustainable future In addition, St. Paul’s Hospital continues to advance low-carbon operations through its collaboration with Shell, taking a multi-pronged approach to building a low-carbon energy ecosystem. This includes the installation of two 50kW Shell Recharge fast-charging facilities in the hospital’s parking lot, providing visitors and staff with a more environmentally friendly and convenient energy option. At the same time, the hospital has adopted low-carbon fuel solutions and actively participated in Shell’s CO₂ Compensation Programme, supporting independently verified environmental, technology, and waste management projects. Through a simple and cost-efficient approach, these initiatives help compensate unavoidable carbon emissions from daily operations while promoting sustainable development in the communities where the projects are located.
Together, these initiatives not only enhance the hospital’s overall sustainability performance but also encourage the healthcare sector to explore low-carbon operational models, contributing to a healthier and more sustainable future.
Shell will continue to work with St. Paul’s Hospital and other partners to promote practical low-carbon solutions, which fully support Hong Kong’s goal of achieving carbon neutrality by 2050 and create a sustainable environment for future generations.
Notes:
Shell Renewable Diesel Blend R33 contains up to 33% ISCC-certified renewable components.
Between 27% and 30% less CO2e. CO2e (carbon dioxide equivalent) includes CO2, CH4, N2O emissions.
The life-cycle assessment of a product’s CO2e emissions includes emissions associated with feedstock production, feedstock transport, fuel production, fuel transportation and distribution, and combustion.
Calculated by comparing to a GHG baseline intensity of 92g CO2e/MJ on a Well-to-Wheel basis, representative of an EN590 B0 diesel and calculated by Shell with emission factors from JEC Well-to-Tank report v5 (Link: https://data.europa.eu/doi/10.2760/959137) and internal Shell studies.
When switching from diesel. Based on Shell’s operability studies and market experience to date. Vehicle handbook and/or label at the fuel tank socket must be checked for OEM approval. Not applicable for passenger cars.
Actual effects and benefits may vary according to vehicle type, vehicle condition and driving style. Compared to EN590 B0 diesel. Not applicable for passenger cars. The tailpipe out emission benefit can be limited for vehicles with advanced exhaust aftertreatment systems.
Between 80% and 90% less CO2e. CO2e (carbon dioxide equivalent) includes CO2, CH4, N2O emissions.
Cautionary Note
The companies in which Shell plc directly and indirectly owns investments are separate legal entities. In this content “Shell”, “Shell Group” and “Group” are sometimes used for convenience to reference Shell plc and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to Shell plc and its subsidiaries in general or to those who work for them. These terms are also used where no useful purpose is served by identifying the particular entity or entities. ”Subsidiaries”, “Shell subsidiaries” and “Shell companies” as used in this content refer to entities over which Shell plc either directly or indirectly has control. The terms “joint venture”, “joint operations”, “joint arrangements”, and “associates” may also be used to refer to a commercial arrangement in which Shell has a direct or indirect ownership interest with one or more parties. The term “Shell interest” is used for convenience to indicate the direct and/or indirect ownership interest held by Shell in an entity or unincorporated joint arrangement, after exclusion of all third-party interest.
Forward-Looking statements
This content contains forward-looking statements (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995) concerning the financial condition, results of operations and businesses of Shell. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements are statements of future expectations that are based on management’s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements. Forward-looking statements include, among other things, statements concerning the potential exposure of Shell to market risks and statements expressing management’s expectations, beliefs, estimates, forecasts, projections and assumptions. These forward-looking statements are identified by their use of terms and phrases such as “aim”; “ambition”; ”anticipate”; “aspire”, “aspiration”, ”believe”; “commit”; “commitment”; ”could”; “desire”; ”estimate”; ”expect”; ”goals”; ”intend”; ”may”; “milestones”; ”objectives”; ”outlook”; ”plan”; ”probably”; ”project”; ”risks”; “schedule”; ”seek”; ”should”; ”target”; “vision”; ”will”; “would” and similar terms and phrases. There are a number of factors that could affect the future operations of Shell and could cause those results to differ materially from those expressed in the forward-looking statements included in this content, including (without limitation): (a) price fluctuations in crude oil and natural gas; (b) changes in demand for Shell’s products; (c) currency fluctuations; (d) drilling and production results; (e) reserves estimates; (f) loss of market share and industry competition; (g) environmental and physical risks, including climate change; (h) risks associated with the identification of suitable potential acquisition properties and targets, and successful negotiation and completion of such transactions; (i) the risk of doing business in developing countries and countries subject to international sanctions; (j) legislative, judicial, fiscal and regulatory developments including tariffs and regulatory measures addressing climate change; (k) economic and financial market conditions in various countries and regions; (l) political risks, including the risks of expropriation and renegotiation of the terms of contracts with governmental entities, delays or advancements in the approval of projects and delays in the reimbursement for shared costs; (m) risks associated with the impact of pandemics, regional conflicts, such as the Russia-Ukraine war and the conflict in the Middle East, and a significant cyber security, data privacy or IT incident; (n) the pace of the energy transition; and (o) changes in trading conditions. No assurance is provided that future dividend payments will match or exceed previous dividend payments. All forward-looking statements contained in this content are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Additional risk factors that may affect future results are contained in Shell plc’s Form 20-F for the year ended December 31, 2025 (available at www.shell.com/investors/news-and-filings/sec-filings.html and www.sec.gov). These risk factors also expressly qualify all forward-looking statements contained in this contentand should be considered by the reader. Each forward-looking statement speaks only as of the date of this content. Neither Shell plc nor any of its subsidiaries undertake any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information. In light of these risks, results could differ materially from those stated, implied or inferred from the forward-looking statements contained in this content.
Shell’s net carbon intensity
Also, in this contentwe may refer to Shell’s “net carbon intensity” (NCI), which includes Shell’s carbon emissions from the production of our energy products, our suppliers’ carbon emissions in supplying energy for that production and our customers’ carbon emissions associated with their use of the energy products we sell. Shell’s NCI also includes the emissions associated with the production and use of energy products produced by others which Shell purchases for resale. Shell only controls its own emissions. The use of the terms Shell’s “net carbon intensity” or NCI is for convenience only and not intended to suggest these emissions are those of Shell plc or its subsidiaries.
Shell’s net-zero emissions target
Shell’s operating plan and outlook are forecasted for a three-year period and ten-year period, respectively, and are updated every year. They reflect the current economic environment and what we can reasonably expect to see over the next three and ten years. Accordingly, the outlook reflects our combined Scope 1 and 2 target, NCI target and our oil products ambition over the next ten years. However, Shell’s operating plan and outlook cannot reflect our 2050 net-zero emissions target, as this target is outside our planning period. Such future operating plans and outlooks could include changes to our portfolio, efficiency improvements and the use of carbon capture and storage and carbon credits. In the future, as society moves towards net-zero emissions, we expect Shell’s operating plans and outlooks to reflect this movement. However, if society is not net zero in 2050, as of today, there would be significant risk that Shell may not meet this target.
Forward-Looking non-GAAP measures
This content may contain certain forward-looking non-GAAP measures such as free cash flow and underlying operating expenses. We are unable to provide a reconciliation of these forward-looking non-GAAP measures to the most comparable GAAP financial measures because certain information needed to reconcile those non-GAAP measures to the most comparable GAAP financial measures is dependent on future events some of which are outside the control of Shell, such as oil and gas prices, interest rates and exchange rates. Moreover, estimating such GAAP measures with the required precision necessary to provide a meaningful reconciliation is extremely difficult and could not be accomplished without unreasonable effort. Non-GAAP measures in respect of future periods which cannot be reconciled to the most comparable GAAP financial measure are calculated in a manner which is consistent with the accounting policies applied in Shell plc’s consolidated financial statements.
The contents of websites referred to in this content do not form part of this content.
We may have used certain terms, such as resources, in this content that the United States Securities and Exchange Commission (SEC) strictly prohibits us from including in our filings with the SEC. Investors are urged to consider closely the disclosure in our Form 20-F, File No 1-32575, available on the SEC website www.sec.gov. Hashtag: #Shell #StPaulsHospital #ESG #LowCarbon
The issuer is solely responsible for the content of this announcement.
About Shell
Shell Hong Kong (Shell) is an operating company of Shell plc – a global group of energy and petrochemical companies which use advanced technologies and take an innovative approach to help build a sustainable energy future. With more than 100 years of history locally, Shell supplies Hong Kong and Macau with a wide range of oil products from its technologically advanced Tsing Yi Installation. Shell’s business activities include Retail filling and service stations, fuel and lubricants to Commercial sectors, Bitumen, Aviation fuel, Marine fuel and lubricants. As a responsible corporate citizen in Hong Kong, Shell actively contributes to the well-being of the community through its social investment programmes.
About Shell Renewable Diesel
Shell Renewable Diesel is a high-quality Hydrotreated Vegetable Oil (HVO) made with 100% renewable bio-components such as used cooking oil, animal fats, crop-based or other wastes through hydrogenation (treatment with hydrogen). Compared to EN 590 B0 diesel 4, Shell Renewable Diesel can reduce CO2eemissions by up to 90%7 on a lifecycle basis 3.
Shell Renewable Diesel Blend R331 contains up to 33% renewable content — including 7% Fatty Acid Methyl Ester (FAME) and 26% Hydrotreated Vegetable Oil (HVO) — and complies with the European EN 590 diesel standard. It offers up to 30%2 less CO2e emissions on a life cycle basis3 compared to EN 590 B0 diesel4
About Shell’s CO₂ Compensation Programme
Shell is one of the most established traders of carbon credits in the world. On the journey to reduce carbon emissions, Shell offers commercial customers carbon offset solutions that provide a simple and cost-effective way to offset hard-to-abate emissions. Shell automatically helps commercial customers calculate their carbon emissions and offsets them through carbon credits generated from various environmental, technology and waste management projects – such as initiatives related to protecting or re-developing natural ecosystems like forests, grasslands and wetlands, as well as investing in renewable energy and low-emission cooking appliances – to reduce concentrations of greenhouse gases in the atmosphere.
These projects include the Reducing Emissions from Deforestation and Forest Degradation (REDD+) project in Congo, the protection of peat swamp forests in Indonesia, and tropical forest protection projects in Acre, Brazil. Taking the Katingan Mentaya Wildlife and Conservation Project in Indonesia as an example, it protects approximately 150,000 hectares of intact peat swamp forest and five endangered species, generating an average of 7.45 million carbon credits each year (equivalent to offsetting 7.45 million tonnes of CO2e) – an impact equivalent to removing 2 million cars from the road each year, making a significant contribution to global carbon reduction.
Chao Anouvong Stadium is on track for completion in October 2026. Funded by the Japanese government, the renovation will introduce accessible features including ramps, elevators, braille handrails and wheelchair seating. Vietiane, Laos. 17 June 2026. (Photo: The Laotian Times)
Vientiane’s Chao Anouvong Stadium renovation has surpassed 70 percent completion and remains on schedule for handover in October 2026.
Shuji Hayashi, senior architect at Azusa Sekkei, the project’s consulting firm, told the Laotian Times on 17 June that construction has exceeded 70 percent of the overall plan and remains ahead of schedule.
Concept image of the renovated Chao Anouvong Stadium in Vientiane, Laos. (Photo credit: Azusa Sekki Co., Ltd.)
“The renovation is scheduled to be completed in October 2026 and will be handed over to the Government of Laos accordingly,” said Risa Shibata, the Japan International Cooperation Agency (JICA) officer overseeing the project.
As the implementing agency for the Japanese government’s grant aid, JICA is responsible for supervising the project on Japan’s behalf.
Risa said major structural work has largely been completed, with interior construction and equipment installation set to continue over the coming months.
Japan-Funded Overhaul
The project is valued at JPY 4.171 billion (approximately USD 29 million) and is funded through Japanese government grant aid. Hazama Ando – Toa Road JV, a leading Japanese joint venture, is implementing the construction.
The grant agreement was originally signed in December 2023, but work began in January 2025.
A Stadium Built for Everyone
Design visualization of the main amphitheater at Chao Anouvong Stadium in Vientiane, Laos. (Photo credit: Azusa Sekkei Co., Ltd.)
The renovated stadium will accommodate 2,767 people, 1,327 seats at the main amphitheater and 1,440 at the back amphitheater, including dedicated zones for wheelchair users.
It will feature a full track and field facility, high-level lighting systems, and a LED scoreboard. The interior will include athlete locker rooms, referee and training rooms, a medical room, meeting rooms, shops, and several multi-purpose rooms.
Disability-inclusive design is central to the project.
Design visualization of the back amphitheater at Chao Anouvong Stadium in Vientiane, Laos. (Photo credit: Azusa Sekkei Co., Ltd.)
The stadium will be equipped with elevators, braille handrails in the stands, restrooms, staircases, and reception areas, as well as slopes at entrances and wheelchair-accessible seating throughout.
“The stadium is targeted for all,” Risa said. “It will not only be a place for athletes to participate in sports events, but a space for everyone in the community of all ages, genders and disabilities to gather together for both sports and cultural events.”
According to data published by the Ministry of Education and Sports in 2019, the stadium served around 100,000 users annually. That figure is expected to rise to approximately 140,000 once the facility reopens.
Chao Anouvong Stadium is on track for completion in October 2026. Viantiane, Laos. 17 June 2026. (Photo: Thongsavanh Souvannasane/Laotian Times)
Eye on SEA Games 2031
Looking further ahead, the renovated stadium is expected to support the 36th Southeast Asian Games, which Laos is scheduled to host in 2031.
The facility is anticipated to serve as a supporting venue alongside the National Stadium KM16, Laos’s largest sports facility, which was first introduced when the country hosted the SEA Games for the first time in 2009.
Once completed, the renovated stadium is expected to enhance Laos’ sports infrastructure and future regional events.
Chao Anouvong Stadium is on track for completion in October 2026. Vientiane, Laos. 17 June 2026. (Photo: Thongsavanh Souvannasane/Laotian Times)
Laos welcomes Iran–US memorandum aimed at easing Middle East tensions, praising Pakistan’s mediation and urging continued negotiations for peace.
The Ministry of Foreign Affairs of Laos has expressed satisfaction over the signing of a Memorandum of Understanding between Iran and the United States aimed at easing tensions and advancing efforts to resolve conflict in the Middle East.
In a statement issued by a ministry spokesperson, Laos welcomed the agreement reached on 15 June, calling it a positive step toward reducing hostilities and reopening dialogue between the two countries.
Laos also congratulated Pakistan and other involved countries for their key role in helping to mediate the conflict and support negotiations.
According to the statement, the Ministry of Foreign Affairs hopes the memorandum will serve as a starting point for continued talks and long-term peace and stability in the Middle East.
Months of Negotiations
The Memorandum of Understanding follows several months of direct and indirect negotiations between Iran and the United States after tensions escalated in early 2026.
The crisis deepened after maritime incidents in the Gulf and retaliatory strikes linked to regional allies, which disrupted shipping routes and raised global concern over energy supplies passing through the Strait of Hormuz.
On 7 March, the United States, Israel, and Iran agreed to a two-week ceasefire in the Middle East, temporarily pausing fighting and reopening key oil shipping lanes through the Strait of Hormuz. The agreement, brokered with Pakistan’s involvement, was aimed at stabilising a rapidly escalating conflict that had triggered global energy disruptions.
The war began on 28 February after US and Israeli strikes in Iran killed Supreme Leader Ali Khamenei, prompting Tehran to shut the Strait of Hormuz and launch retaliatory attacks on Israeli territory and US military bases across the region. The Strait carries around one-fifth of global oil supply, and its closure immediately sent shockwaves through international energy markets.
Impact on Laos
For Laos, the impact was severe. As Thailand supplies more than 97 percent of its refined fuel, Bangkok’s partial suspension of exports on 1 March contributed to a nationwide shortage. Although Laos and Myanmar were exempt from the full ban, deliveries still fell significantly. Within weeks, Laos faced its worst fuel crisis in years.
Diesel prices surged by 163 percent. Petrol prices also jumped more than 80 percent, with frequent adjustments throughout March. At the peak of the crisis, over half of Laos’ fuel stations shut down, causing long queues and shortages that disrupted transport, farming, and electricity supply.
The Lao government responded with tax cuts, emergency fuel distribution, and rationing measures, while also importing fuel from Vietnam and Thailand to stabilise supply. These interventions gradually eased shortages, and most stations have since reopened.
SINGAPORE, June 18, 2026 /PRNewswire/ — InCorp Singapore, An Ascentium Company, and Shaw Investment A.P.A.C. have entered into a strategic collaboration to support the internationalisation of high-potential Chinese technology companies, innovation-led enterprises and family offices through Singapore.
The collaboration forms part of Shaw Investment’s China–Singapore–ASEAN internationalisation platform, supporting qualified enterprises aligned with China’s 15th Five-Year Plan to establish regional headquarters, access capital and international markets, and expand through structured, compliant cross-border investment frameworks.
Priority sectors include artificial intelligence, advanced manufacturing, robotics, digital infrastructure, semiconductors, biotechnology, life sciences, green energy, smart mobility, enterprise software and other strategic emerging industries identified as key drivers of China’s future economic development.
Dr Ivan Lew, Executive Chairman of Shaw Investment A.P.A.C., said:
“China’s 15th Five-Year Plan places significant emphasis on technological innovation, advanced manufacturing, digital transformation, green development and the cultivation of globally competitive enterprises. As Chinese companies continue to move up the value chain, many will increasingly seek to establish regional and international operations beyond China as they pursue new markets, strategic partnerships and global growth opportunities.
Singapore is uniquely positioned to serve as the bridge between Chinese innovation, ASEAN growth opportunities and international capital. At Shaw Investment, we are creating an ecosystem that connects enterprises with family offices, financial institutions, technology partners and professional advisers across multiple markets.”
Under the collaboration, InCorp Singapore has been appointed as Shaw Investment’s preferred business services partner, providing corporate structuring, governance, accounting, tax, compliance, immigration and administrative support to companies establishing operations in Singapore and expanding across ASEAN and international markets.
KG Tan, CEO of InCorp Singapore, said:
“International expansion requires much more than setting up an entity in another jurisdiction. Businesses need the right structure, strong governance, reliable compliance support and experienced advisers who understand how different regulatory environments interact.
Through this partnership with Shaw Investment, we are excited to help participating Chinese enterprises translate their expansion strategies into well-structured and compliant operations in Singapore. Our goal is to give business leaders the operational confidence and local support they need to focus on long-term growth.”
Cody Lee, Executive Director of Shaw Investment A.P.A.C., said:
“Shaw Investment is building a practical China–Singapore–ASEAN growth corridor through initiatives involving Zhongguancun, Forbes China AI50, leading financial institutions, family office networks and a growing ecosystem of public and private sector partners. We support international enterprises beyond incorporation by helping them access customers, pilot projects, strategic partnerships, capital and compliant cross-border investment pathways.
By combining Shaw Investment’s internationalisation platform with InCorp Singapore’s operational expertise and Ascentium’s wider global reach, we provide companies with a coordinated pathway from market entry and structuring through to execution, compliance and regional expansion.”
Gary Tok, Group Chief Commercial Officer of Ascentium, said:
“This partnership brings together complementary capabilities across strategic advisory, capital deployment and professional services execution. Shaw Investment provides access to an important ecosystem of internationally ambitious Chinese enterprises, while InCorp and the wider Ascentium platform provide the infrastructure and expertise needed to support their expansion.
As InCorp Singapore prepares to transition to the Ascentium brand, this collaboration reflects our broader ambition to connect businesses with integrated expertise across markets and provide a consistent, client-led experience wherever their growth takes them.”
The collaboration is expected to strengthen connectivity between China’s enterprise ecosystem and Singapore’s corporate, financial and professional services infrastructure, helping internationally ambitious companies build credible and compliant foundations for global growth.
About InCorp Singapore
InCorp Global, An Ascentium Company, is a leading corporate services provider offering corporate, compliance, accounting, tax, human resources, risk assurance, and advisory services to businesses operating in Singapore and across international markets.
InCorp is part of Ascentium, a global business services platform. This brings together InCorp’s local expertise in corporate, accounting, tax, and compliance services with Ascentium’s global network of over 3,000 professionals across 58 cities and 27 markets.
About Shaw Investment A.P.A.C. Pte. Ltd.
Shaw Investment A.P.A.C. Pte Ltd is a Singapore-based single-family office and strategic investment platform with interests across financial services, infrastructure, energy, telecommunications, technology, healthcare, engineering, marine, education and industrial sectors.
With more than USD3.5 billion in assets and business interests under management and oversight, Shaw Investment serves as a platform architect focused on internationalisation, capital mobilisation and strategic ecosystem development.
Through partnerships with family offices, financial institutions, technology ecosystems, government agencies and professional service providers, Shaw Investment supports enterprises seeking to establish and expand internationally through Singapore. Its growing China–Singapore–ASEAN platform facilitates outbound investment, cross-border structuring, strategic partnerships, market access and capital formation initiatives, enabling companies to leverage Singapore as a regional headquarters and gateway to ASEAN and global markets.
LAS VEGAS, June 18, 2026 /PRNewswire/ — As MAXHUB takes part in InfoComm 2026, the trusted solution provider in integrated commercial display and unified communications is showcasing its latest innovations in AI-powered collaboration and professional display technology. The exhibition runs from June 17–19 at the Las Vegas Convention Center.
Opening Session at MAXHUB Booth
So, what can visitors experience at MAXHUB Booth C7036?
AI Meeting Experience in Action
At InfoComm 2026, MAXHUB is demonstrating its AI Meeting Experience on the XBoard V7, showcasing how AI can simplify hybrid collaboration through intelligent audio and video optimization, real-time transcription, AI-assisted meeting controls, and automated meeting summaries.
Visitors can explore AI-enhanced workflows designed to improve productivity before, during, and after meetings. Live meeting scenarios are simultaneously streamed to MAXHUB CMB Series commercial displays via NDI®, demonstrating seamless, low-latency content distribution across meeting and display environments.
Smarter Solutions for Modern Workspaces
Alongside its AI collaboration capabilities, MAXHUB is presenting a portfolio of solutions designed to create more connected, efficient, and scalable workplace experiences.
Highlights include the CMB Series commercial displays with built-in NDI® technology, the Pivot⁺ platform for centralized device and content management, and an expanded Microsoft Teams Rooms portfolio featuring the Scheduling Panel SP10, Mic Pod DM30, and Universal Console TCP33T.
Further underscoring MAXHUB’s commitment to innovation, the MAXHUB XBar W70 Kit was recognized with the SCN Installation Product Award for Most Innovative AI-Powered Product at InfoComm 2026.
Visitors can also explore the FA27 Series Indoor LED displays, the XBoard V7 collaboration board, and the WT15S wireless screen sharing dongle, providing flexible solutions for communication, collaboration, and content sharing across a variety of environments.
Global Leadership, Local Presence
MAXHUB holds the No.1 global market share in collaboration boards and all-in-one LED displays, according to Futuresource and TrendForce. Today, the company serves customers in more than 140 countries and supports them through local teams across 35 countries worldwide.
Visit MAXHUB at Booth C7036
Throughout InfoComm 2026, visitors can experience live demonstrations of MAXHUB’s latest collaboration and display technologies while connecting with solution specialists to explore workspace solutions tailored to their business needs.
For more information about MAXHUB, visit MAXHUB.com or stop by Booth C7036 during InfoComm 2026.
SEOUL, South Korea, June 18, 2026 /PRNewswire/ — JNJ International Co., Ltd., a comprehensive automotive parts exporter, announced its participation in Automechanika Mexico 2026, which will be held from July 8 to July 10 in Mexico City, Mexico.
The company specializes in supplying a wide range of automotive parts for Korean, Japanese, Chinese, and European vehicles. Its product portfolio includes genuine parts, OEM products, and aftermarket components, providing customers with a convenient one-stop sourcing solution.
At the exhibition, JNJ International Co., Ltd. will showcase its extensive lineup of automotive components, including engine, suspension, and electrical system parts. The company will also introduce its newly launched Plan2 OEM Shock Absorber, designed to deliver reliable quality and competitive value for global markets.
Mexico serves as a strategic gateway to both North and Latin America, making it an important market for international automotive suppliers. Through its participation in Automechanika Mexico, JNJ International Co., Ltd. aims to strengthen relationships with local distributors, expand its customer base, and explore new business opportunities across the region.
“We look forward to meeting industry professionals and potential partners from across Latin America,” said a spokesperson for JNJ International Co., Ltd. “This exhibition will provide an excellent opportunity to demonstrate our product competitiveness and strengthen our global business network.”
SUZHOU, China, June 18, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Biosafety Testing Center in Suzhou has successfully passed a Good Manufacturing Practice (GMP) inspection by the European Medicines Agency (EMA) with zero critical findings. This marks the fourth time the facility has successfully received EMA GMP certificate.
The inspection supported the European Union marketing authorization application for a total of 19 biologics from 13 clients, with the majority developed and manufactured on WuXi Biologics’ integrated platform. These products span a range of biologics modalities, including antibodies, enzymes, and fusion proteins. The EMA inspection focused on biosafety quality control testing for cell banks and commercial unprocessed bulk associated with these products.
GMP-compliant biosafety quality control testing of commercial unprocessed bulk is a key part of pre-license inspections for biologics seeking marketing authorization in the European Union and remains a focus in routine inspections of commercial products. The four-day inspection covered areas such as quality management, facilities and equipment, testing methods, standard operating procedures, computerized systems and personnel. The Suzhou facility’s quality system, infrastructure, technical capabilities, data integrity and organizational management were highly recognized by the EMA.
Dr. Chris Chen, CEO of WuXi Biologics, commented: “From preliminary safety validation at cell bank and harvest stages to final quality control at commercial batch release, biosafety testing spans critical stages across the entire lifecycle of biologics, ensuring compliance with rigorous regulatory requirements from development through commercialization. We remain committed to maintaining a high-quality system aligned with global GMP standards as a cornerstone to ensure product quality. This capability is consistently demonstrated and implemented across our global network, reflecting our long-standing commitment to enabling our partners and ultimately benefiting patients worldwide.”
WuXi Biologics’ Biosafety Testing Center has two facilities in Suzhou and Shanghai, offering comprehensive services including cell bank characterization for CHO, HEK293, and E. coli expression systems, diverse biologics biosafety testing, GMP-compliant release testing for commercial products, and GLP-compliant viral clearance studies supported by high-quality in-house virus production platform. As of December 2025, WuXi Biologics’ Biosafety Testing Center has successfully enabled over 1,700 IND or BLA applications. Its high-quality system and technical capabilities have been widely recognized by global regulatory authorities and clients.
In additional to EMA, WuXi Biologics’ Biosafety Testing Center has received multiple recognitions from other global regulatory authorities. It has successfully completed remote interactive evaluation by the U.S. Food and Drug Administration (FDA), and has passed inspections by China National Accreditation Service for Conformity Assessment (CNAS), National Medical Products Administration (NMPA), Health Canada (HC), the Therapeutic Goods Administration (TGA) of Australia, and the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan, as well as more than 510 quality audits conducted by global clients.
About WuXi Biologics
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide*.
With over 13,000 employees in China, the United States, Ireland, Germany, and Singapore — including experts and scientists in biologics R&D and manufacturing, technology innovation, and operational excellence — WuXi Biologics leverages its technologies and expertise to deliver efficient, cost-effective, and scalable biologics solutions tailored to meet clients’ needs. By embedding digital capability and infrastructure across the full biopharmaceutical value chain, the company turns data, computation, and prediction into transparent client experience, faster development, intelligent operations, and more efficient manufacturing. As of April 30, 2026, WuXi Biologics is supporting 982 integrated client projects, including 78 in Phase III and 25 in commercial manufacturing, with complex modalities representing more than half of the entire project portfolio.
WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while demonstrating exemplary Environmental, Social and Governance (ESG) practices. Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts, and promote responsible practices that empower the entire value chain.
